Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedzicha, J. A.
(Chest. 2002;121:136S-141S.)
© 2002 American College of Chest Physicians

Exacerbations*

Etiology and Pathophysiologic Mechanisms

Jadwiga A. Wedzicha, MD

* From the Academic Unit of Respiratory Medicine, St. Bartholomew’s Hospital and Royal London School of Medicine and Dentistry, Dominion House, London, UK.

Correspondence to: Jadwiga A. Wedzicha, MD, Academic Unit of Respiratory Medicine, St. Bartholomew’s Hospital and Royal London School of Medicine and Dentistry, Dominion House, West Smithfield, London EC1A 7BE, United Kingdom; e-mail: J.A.Wedzicha{at}qmul.ac.uk

Some patients with COPD are prone to frequent exacerbations, which are an important determinant of health status. Such patients have elevated airway cytokine levels, suggesting the presence of increased inflammation that may increase their susceptibility to exacerbation. The inflammatory response during a COPD exacerbation is variable, but increases in interleukin-6 levels during the exacerbation are related to the presence of a common cold. Rhinovirus infection is the most important etiologic factor in COPD exacerbations and is an important target for preventive therapy. The reduction of COPD exacerbations will have an important impact on the considerable morbidity and mortality associated with COPD.

Key Words: bacterial infection • COPD • endothelin-1 • epidemiology • exacerbations • interleukin-6 • interleukin-8 • pollution • rhinovirus • virus infection




This article has been cited by other articles:


Home page
 ChestHome page
S. J. Carr, R. S. Goldstein, and D. Brooks
Acute Exacerbations of COPD in Subjects Completing Pulmonary Rehabilitation
Chest, July 1, 2007; 132(1): 127 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. Fujimoto, M. Yasuo, K. Urushibata, M. Hanaoka, T. Koizumi, and K. Kubo
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Eur. Respir. J., April 1, 2005; 25(4): 640 - 646.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J. D Kriesel and W. A Sibley
The case for rhinoviruses in the pathogenesis of multiple sclerosis
Multiple Sclerosis, February 1, 2005; 11(1): 1 - 4.
[PDF]

Home page
 Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma
Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.